Skip to main content
Erschienen in: Rheumatology International 1/2013

01.01.2013 | Original Article

The effect of hyaluronic acid on osteopontin and CD44 mRNA of fibroblast-like synoviocytes in patients with osteoarthritis of the knee

verfasst von: Fang-Jie Zhang, Shu-Guang Gao, Ling Cheng, Jian Tian, Wen-Shuo Xu, Wei Luo, Yang Song, Yang Yang, Guang-Hua Lei

Erschienen in: Rheumatology International | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to investigate the effect of hyaluronic acid (HA) on the expression of osteopontin (OPN) and CD44 mRNA of fibroblast-like synoviocytes (FLS) in the patients with osteoarthritis (OA) of the knee. FLS were obtained from the knees of 10 patients with OA. Real-time quantitative polymerase chain reaction (Q-PCR) was used to assess the expression of the OPN mRNA and CD44 mRNA. The relative OPN mRNA expression in HA group (6.47 ± 2.30-fold) was significantly higher than in the control group (P = 0.045, P < 0.05), while in HYL group (0.65 ± 0.21-fold) it was lower than in the control group (P = 0.037, P < 0.05), and the difference in OPN mRNA expression between HA group and HYL group also showed statistically significant (P = 0.001, P < 0.05); however, there was no significant difference between each group of the relative CD44 mRNA expression (P > 0.05). Our study showed that HA can upregulate OPN mRNA expression in OA fibroblast-like synoviocytes, and the high expression of OPN mRNA in OA may be a result of increased HA level of OA synovitis; however, HA cannot affect the CD44 mRNA expression in OA fibroblast-like synoviocytes, and the high expression of CD44 mRNA in OA may be not a result of increased HA level of OA synovitis.
Literatur
1.
Zurück zum Zitat Malemud CJ, Islam N, Haqqi TM (2003) Pathophysiological mechanisms in osteoarthritis lead to novel therapeutic strategies. Cells Tissues Organs 174:34–48PubMedCrossRef Malemud CJ, Islam N, Haqqi TM (2003) Pathophysiological mechanisms in osteoarthritis lead to novel therapeutic strategies. Cells Tissues Organs 174:34–48PubMedCrossRef
2.
Zurück zum Zitat Dahl LB, Dahl IM, Engstro m-Laurent A, Granath K (1985) Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis 44:817–822PubMedCrossRef Dahl LB, Dahl IM, Engstro m-Laurent A, Granath K (1985) Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis 44:817–822PubMedCrossRef
3.
Zurück zum Zitat Xu G, Nie H, Li N, Zheng W, Zhang D, Feng G (2005) Role of osteopontin in amplification and perpetuation of rheumatoid synovitis. J Clin Invest 115:1060–1067PubMed Xu G, Nie H, Li N, Zheng W, Zhang D, Feng G (2005) Role of osteopontin in amplification and perpetuation of rheumatoid synovitis. J Clin Invest 115:1060–1067PubMed
4.
Zurück zum Zitat Gao SG, Li KH, Zeng KB, Tu M, Xu M, Lei GH (2010) Elevated osteopontin level of synovial fluid and articular cartilage is associated with disease severity in knee osteoarthritis patients. Osteoarthr Cartil 18:82–87PubMedCrossRef Gao SG, Li KH, Zeng KB, Tu M, Xu M, Lei GH (2010) Elevated osteopontin level of synovial fluid and articular cartilage is associated with disease severity in knee osteoarthritis patients. Osteoarthr Cartil 18:82–87PubMedCrossRef
5.
Zurück zum Zitat Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B (1990) CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303–1313PubMedCrossRef Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B (1990) CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303–1313PubMedCrossRef
6.
Zurück zum Zitat Weber GF, Ashkar S, Glimcher MJ, Cantor H (1996) Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271:509–512PubMedCrossRef Weber GF, Ashkar S, Glimcher MJ, Cantor H (1996) Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271:509–512PubMedCrossRef
7.
Zurück zum Zitat Dunn S, Kolomytkin OV, Waddell DD, Marino AA (2009) Hyaluronan-binding receptors: possible involvement in osteoarthritis. Mod Rheumatol 19:151–155PubMedCrossRef Dunn S, Kolomytkin OV, Waddell DD, Marino AA (2009) Hyaluronan-binding receptors: possible involvement in osteoarthritis. Mod Rheumatol 19:151–155PubMedCrossRef
8.
Zurück zum Zitat Stebulis JA, Rossetti RG, Atez FJ, Zurier RB (2005) Fibroblast-like synovial cells derived from synovial fluid. J Rheumatol 32:301–306PubMed Stebulis JA, Rossetti RG, Atez FJ, Zurier RB (2005) Fibroblast-like synovial cells derived from synovial fluid. J Rheumatol 32:301–306PubMed
9.
Zurück zum Zitat Matsui Y, Iwasaki N, Kon S, Takahashi D, Morimoto J, Matsui Y, Denhardt DT, Rittling S, Minami A, Uede T (2009) Accelerated development of aging-associated and instability-induced osteoarthritis in osteopontin-deficient mice. Arthr Rheum 60:2362–2371CrossRef Matsui Y, Iwasaki N, Kon S, Takahashi D, Morimoto J, Matsui Y, Denhardt DT, Rittling S, Minami A, Uede T (2009) Accelerated development of aging-associated and instability-induced osteoarthritis in osteopontin-deficient mice. Arthr Rheum 60:2362–2371CrossRef
10.
Zurück zum Zitat Attur MG, Dave MN, Stuchin S, Kowalski AJ, Steiner G, Abramson SB, Denhardt DT, Amin AR (2001) Osteopontin: an intrinsic inhibitor of inflammation in cartilage. Arthr Rheum 44:578–584CrossRef Attur MG, Dave MN, Stuchin S, Kowalski AJ, Steiner G, Abramson SB, Denhardt DT, Amin AR (2001) Osteopontin: an intrinsic inhibitor of inflammation in cartilage. Arthr Rheum 44:578–584CrossRef
11.
Zurück zum Zitat Larkin J, Renukaradhya GJ, Sriram V, Du W, Gervay-Hague J, Brutkiewicz RR (2006) CD44 differentially activates mouse NK T cells and conventional T cells. J Immunol 177:268–279PubMed Larkin J, Renukaradhya GJ, Sriram V, Du W, Gervay-Hague J, Brutkiewicz RR (2006) CD44 differentially activates mouse NK T cells and conventional T cells. J Immunol 177:268–279PubMed
12.
Zurück zum Zitat Clark RA, Alon R, Springer TA (1972) CD44 and hyaluronan-dependent rolling interactions of lymphocytes on tonsillar stroma. J Cell Biol 134:1075–1087CrossRef Clark RA, Alon R, Springer TA (1972) CD44 and hyaluronan-dependent rolling interactions of lymphocytes on tonsillar stroma. J Cell Biol 134:1075–1087CrossRef
13.
Zurück zum Zitat de la Motte CA, Hascall VC, Drazba J, Bandyopadhyay SK, Strong SA (2003) Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid: polycytidylic acid: inter-alpha-trypsin inhibitor is crucial to structure and function. Am J Pathol 163:121–133CrossRef de la Motte CA, Hascall VC, Drazba J, Bandyopadhyay SK, Strong SA (2003) Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid: polycytidylic acid: inter-alpha-trypsin inhibitor is crucial to structure and function. Am J Pathol 163:121–133CrossRef
14.
Zurück zum Zitat Mori H, Tomari T, Koshikawa N, Kajita M, Itoh Y, Sato H, Tojo H, Yana I, Seiki M (2002) CD44 directs membrane-type 1 matrix metalloproteinase to lemellipodia by associating with its hemopexin-like domain. EMBO J 21:3949–3959PubMedCrossRef Mori H, Tomari T, Koshikawa N, Kajita M, Itoh Y, Sato H, Tojo H, Yana I, Seiki M (2002) CD44 directs membrane-type 1 matrix metalloproteinase to lemellipodia by associating with its hemopexin-like domain. EMBO J 21:3949–3959PubMedCrossRef
15.
Zurück zum Zitat Mikecz K, Dennis K, Shi M, Kim JH (1999) Modulation of hyaluronan receptor (CD44) function in vivo in a murine model of rheumatoid arthritis. Arthr Rheum 42:659–668CrossRef Mikecz K, Dennis K, Shi M, Kim JH (1999) Modulation of hyaluronan receptor (CD44) function in vivo in a murine model of rheumatoid arthritis. Arthr Rheum 42:659–668CrossRef
16.
Zurück zum Zitat Neidhart M, Gay RE, Gay S (2000) Anti–interleukin-1 and anti-CD44 interventions producing significant inhibition of cartilage destruction in an in vitro model of cartilage invasion by rheumatoid arthritis synovial fibroblasts. Arthr Rheum 43:1719–1728CrossRef Neidhart M, Gay RE, Gay S (2000) Anti–interleukin-1 and anti-CD44 interventions producing significant inhibition of cartilage destruction in an in vitro model of cartilage invasion by rheumatoid arthritis synovial fibroblasts. Arthr Rheum 43:1719–1728CrossRef
17.
Zurück zum Zitat Weigel JA, Raymond RC, McGary C, Singh A, Weigel PH (2003) A blocking antibody to the hyaluronan receptor for endocytosis (HARE) inhibits hyaluronan clearance by perfused liver. J Biol Chem 14:9808–9812CrossRef Weigel JA, Raymond RC, McGary C, Singh A, Weigel PH (2003) A blocking antibody to the hyaluronan receptor for endocytosis (HARE) inhibits hyaluronan clearance by perfused liver. J Biol Chem 14:9808–9812CrossRef
18.
Zurück zum Zitat Stern R, Kogan G, Jedrzejas MJ, Soltés L (2007) The many ways to cleave hyaluronan. Biotechnol Adv 25:537–557PubMedCrossRef Stern R, Kogan G, Jedrzejas MJ, Soltés L (2007) The many ways to cleave hyaluronan. Biotechnol Adv 25:537–557PubMedCrossRef
19.
Zurück zum Zitat Kim MS, Park MJ, Moon EJ, Kim SJ, Lee CH, Yoo H, Shin SH, Song ES, Lee SH (2005) Hyaluronic acid induces osteopontin via the phosphatidylinositol 3-kinase/Akt pathway to enhance the motility of human glioma cells. Cancer Res 65:686–691PubMed Kim MS, Park MJ, Moon EJ, Kim SJ, Lee CH, Yoo H, Shin SH, Song ES, Lee SH (2005) Hyaluronic acid induces osteopontin via the phosphatidylinositol 3-kinase/Akt pathway to enhance the motility of human glioma cells. Cancer Res 65:686–691PubMed
20.
Zurück zum Zitat Martínez-Sanz E, Ossipov DA, Hilborn J, Larsson S, Jonsson KB, Varghese OP (2011) Bone reservoir: injectable hyaluronic acid hydrogel for minimal invasive bone augmentation. J Control Release 152:232–240PubMedCrossRef Martínez-Sanz E, Ossipov DA, Hilborn J, Larsson S, Jonsson KB, Varghese OP (2011) Bone reservoir: injectable hyaluronic acid hydrogel for minimal invasive bone augmentation. J Control Release 152:232–240PubMedCrossRef
21.
Zurück zum Zitat Xu C, Wang Y, Yu X, Chen X, Li X, Yang X, Li S, Zhang X, Xiang AP (2009) Evaluation of human mesenchymal stem cells response to biomimetic bioglass-collagen-hyaluronic acid-phosphatidylserine composite scaffolds for bone tissue engineering. J Biomed Mater Res A 88:264–273PubMed Xu C, Wang Y, Yu X, Chen X, Li X, Yang X, Li S, Zhang X, Xiang AP (2009) Evaluation of human mesenchymal stem cells response to biomimetic bioglass-collagen-hyaluronic acid-phosphatidylserine composite scaffolds for bone tissue engineering. J Biomed Mater Res A 88:264–273PubMed
22.
Zurück zum Zitat Mendes RM, Silva GA, Lima MF, Calliari MV, Almeida AP, Alves JB, Ferreira AJ (2008) Sodium hyaluronate accelerates the healing process in tooth sockets of rats. Arch Oral Biol 53:1155–1162PubMedCrossRef Mendes RM, Silva GA, Lima MF, Calliari MV, Almeida AP, Alves JB, Ferreira AJ (2008) Sodium hyaluronate accelerates the healing process in tooth sockets of rats. Arch Oral Biol 53:1155–1162PubMedCrossRef
23.
Zurück zum Zitat Kim J, Kim IS, Cho TH, Kim HC, Yoon SJ, Choi J, Park Y, Sun K, Hwang SJ (2010) In vivo evaluation of MMP sensitive high-molecular weight HA-based hydrogels for bone tissue engineering. J Biomed Mater Res A 95:673–681PubMed Kim J, Kim IS, Cho TH, Kim HC, Yoon SJ, Choi J, Park Y, Sun K, Hwang SJ (2010) In vivo evaluation of MMP sensitive high-molecular weight HA-based hydrogels for bone tissue engineering. J Biomed Mater Res A 95:673–681PubMed
24.
Zurück zum Zitat Gao C, Guo H, Downey L, Marroquin C, Wei J, Kuo PC (2003) Osteopontin-dependent CD44v6 expression and cell adhesion in HepG2. Carcinogenesis 24:1871–1878PubMedCrossRef Gao C, Guo H, Downey L, Marroquin C, Wei J, Kuo PC (2003) Osteopontin-dependent CD44v6 expression and cell adhesion in HepG2. Carcinogenesis 24:1871–1878PubMedCrossRef
25.
Zurück zum Zitat Cook AC, Chambers AF, Turley EA, Tuck AB (2006) Osteopontin induction of hyaluronan synthase 2 expression promotes breast cancer malignancy. J Biol Chem 281:24381–24389PubMedCrossRef Cook AC, Chambers AF, Turley EA, Tuck AB (2006) Osteopontin induction of hyaluronan synthase 2 expression promotes breast cancer malignancy. J Biol Chem 281:24381–24389PubMedCrossRef
Metadaten
Titel
The effect of hyaluronic acid on osteopontin and CD44 mRNA of fibroblast-like synoviocytes in patients with osteoarthritis of the knee
verfasst von
Fang-Jie Zhang
Shu-Guang Gao
Ling Cheng
Jian Tian
Wen-Shuo Xu
Wei Luo
Yang Song
Yang Yang
Guang-Hua Lei
Publikationsdatum
01.01.2013
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 1/2013
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-2339-3

Weitere Artikel der Ausgabe 1/2013

Rheumatology International 1/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Neu im Fachgebiet Innere Medizin

23.04.2024 | Parkinson-Krankheit | Podcast | Nachrichten

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Professorin Dr. Claudia Trenkwalder, Neurologin

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Krebspatienten impfen: Was? Wen? Und wann nicht?

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Nierenultraschall: Tipps vom Profi

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.